Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: A feasibility study

Investigative Radiology

Volumn 48, Issue 3, 2013, Pages 134-139

  Schipper, Robert Jan ^a   Smidt, Marjolein L ^a   Van Roozendaal, Lori M ^a   Castro, Christian J G ^a   De Vries, Bart ^a   Heuts, Esther M ^a   Keymeulen, Kristien B M I ^a   Wildberger, Joachim E ^a   Lobbes, Marc B I ^a   Beets Tan, Regina G H ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

axillary lymph node dissection; axillary lymph node staging; breast cancer; gadofosveset; MRI

Indexed keywords

GADOFOSVESET;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MORPHOLOGY; MUSCLE TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATHOLOGIST; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; RADIOLOGIST; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; THREE DIMENSIONAL IMAGING;

EID: 84873408853     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318277f056     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Liu CQ, Guo Y, Shi JY, et al. Late morbidity associated with a tumour-negative sentinel lymph node biopsy in primary breast cancer patients: a systematic review. Eur J Cancer. 2009;45:1560-1568.
3. Schulze T, Mucke J, Markwardt J, et al. Long-term morbidity ofpatients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. JSurg Oncol. 2006;93:109-119.
4. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a ran-domized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. NEngl JMed. 2002;347:567-575.
5. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569-575.
6. Cooper KL, Meng Y, Harnan S, et al. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation. Health Technol Assess. 2011;15:1-134.
7. Lahaye GLB, Engelen SME, Voth M, et al. Gadovosfeset trisodium (Vasovist) enhanced MR lymphnode detection: initial observations. Open Magn Reson J. 2009;2:28-32.
8. Lambregts DM, Beets GL, Maas M, et al. Accuracy ofgadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer. Ann Surg. 2011;253: 539-545.
9. Herborn CU, Lauenstein TC, Vogt FM, et al. Interstitial MR lymphography with MS-325: characterization ofnormal and tumor-invaded lymph nodes in a rabbit model. AJR Am JRoentgenol. 2002;179:1567-1572.
10. Lambregts DM, Heijnen LA, Maas M, et al. Gadofosveset-enhanced MRI for the assessment ofrectal cancer lymph nodes: predictive criteria. Abdom Im-aging. 2012. [Epub ahead ofprint].
11. Siesling S, van Dijck JA, Visser O, et al. Trends in incidence of and mortality from cancer in The Netherlands in theperiod 1989-1998. Eur JCancer. 2003; 39:2521-2530.
12. Nori J, Vanzi E, Bazzocchi M, et al. Role ofaxillary ultrasound examination in the selection of breast cancer patients for sentinel node biopsy. Am J Surg. 2007;193:16-20.
13. Pamilo M, Soiva M, Lavast EM. Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. J Ultrasound Med. 1989;8:115-120.
14. Valente SA, Levine GM, Silverstein MJ, et al. Accuracy ofpredicting axillary lymph node positivity by physical examination, mammography, ultrasonogra-phy, and magnetic resonance imaging. Ann Surg Oncol. 2012;19:1825-1830.
15. Alvarez S, Anorbe E, Alcorta P, et al. Role ofsonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol. 2006;186:1342-1348.
16. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881-888.
17. Tan VK, Goh BK, Fook-Chong S, et al. The feasibility and accuracy ofsentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer-a systematic review and meta-analysis. J Surg Oncol. 2011;104:97-103.
18. Mann RM, Kuhl CK, Kinkel K, et al. Breast MRI: guidelines from the Euro-pean Society of Breast Imaging. Eur Radiol. 2008;18:1307-1318.
19. Caudle AS, Hunt KK, Kuerer HM, et al. Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons On-cology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol. 2011;18:2407-2412.
20. Galimberti V, Botteri E, Chifu C, et al. Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Res Treat. 2012; 131:819-825.
21. Pediconi F, Miglio E, Telesca M, et al. Effect ofpreoperative breast magnetic resonance imaging on surgical decision making and cancer recurrence rates. Invest Radiol. 2012;47:128-135.
22. Ei Khouli RH, Jacobs MA, Mezban SD, et al. Diffusion-weighted imaging improves the diagnostic accuracy ofconventional 3.0-T breast MR imaging. Radiology. 2010;256:64-73.
23. Eyal E, Shapiro-Feinberg M, Furman-Haran E, et al. Parametric diffusion tensor imaging of the breast. Invest Radiol. 2012;47:284-291.
24. Mizukoshi W, Kozawa E, Inoue K, et al. (1)H MR spectroscopy with ex-ternal reference solution at 1.5 T for differentiating malignant and benign breast lesions: comparison using qualitative and quantitative approaches. Eur Radiol. 2012. [Epub ahead ofprint].
25. Baltzer PA, Dietzel M, Burmeister HP, et al. Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? Evaluation of an extended protocol in an initial prospective study. AJR Am J Roentgenol. 2011;196:W641-W647.